You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復鋭醫療科技(01696.HK)年度純利達2078.5萬美元 末期息0.11港元
格隆匯 03-18 22:36

格隆匯3月18日丨復鋭醫療科技(01696.HK)公佈,截至2019年12月31日止年度,公司實現收益1.74億美元,同比增長12.7%;毛利9587.4萬美元,同比增長16.5%;純利2078.5萬美元,同比減少4.8%;基本每股4.70美仙,擬派末期息每股0.11港元(含税)。

收益增加主要歸因於脱毛、身體塑形及脂肪移植三大主要治療領域的無創產品及微創產品的銷售增加,超出行業趨勢分析及預測。公司將注意力集中到手術(微創)業務單位上,令公司取得重大研發成就,且收益同比大幅增長16.0%。毛利率為55.3%,而2018年為53.5%。

2019年毛利增幅為16.5%,主要原因是向直銷客户的銷售的比例增加,這產生的利潤率通常較分銷商高。向直銷的轉移是採用價值創造方法的成果,該方法旨在提高我們的品牌知名度及加強品牌定位。在選定區域設立直營辦公室,使公司能夠縮短供應鏈,獲得更高的品牌知名度及確保目標客户羣溝通中的一致性。於2019年,Alma已新設三個分別位於以色列、澳洲及韓國的直銷辦事處。憑藉已有的此種方法,直銷產生的收益於2019年首次超過分銷商產生的收益,直銷產生的收益佔53.9%而分銷商產生的收益佔46.1%。

此外,於2020年,Sisram計劃採用具建設性的顛覆傳統策略,就不久將來的新技術、商業拓展及協同效應進行評估及實踐,以增強公式的全球地位。2020年,集團的工作將戰略性地聚焦於數碼化、品牌和生態圈建立及精益革新。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account